Nalaganje...
Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia
BACKGROUND: Hepatocellular carcinoma as a complication is linked to improved outcomes of thalassemia. MAIN BODY: Published data suggest an incidence of HCC in thalassemia of about 2%. However, since thalassemia is endemic in many under-developed countries where patients have not probably been screen...
Shranjeno v:
| izdano v: | BMC Gastroenterol |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724702/ https://ncbi.nlm.nih.gov/pubmed/33297979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01542-2 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|